Cobalt has represented the shareholders of UAB Ilsanta, a Lithuanian company installing and distributing medical devices and equipment, on the sale of 100% of the company’s shares to UAB ILS Holding. ILS Holding, which is part of the ZIA Valda investment company, was represented by Motieka & Audzevicius.
Ilsanta installs and distributes medical devices and equipment in the Baltic States and represents such producers as Boston Scientific, 3M, Ansell, Swan Morton, Unomedical, and Trumphf.
Ilsanta will complement the portfolio of companies managed by the Pharnasanta Group. The main shareholder of the Pharnasanta Group, which together with related entities holds 57.5% of the shares, is AB ZIA Valda.
“This transaction confirms prevailing trends in the market, when large companies consolidate their business by way of acquisition, and the number of companies managed by individual natural persons in the market is declining," said Cobalt Lithuania Managing Partner Irmantas Norkus. "There will soon appear more such deals, and acquisitions will remain an attractive way for business to more rapidly expand and enter new markets.”
The Cobalt team was led by Norkus, who was supported by Associate Mantas Juska.
Motieka & Audzevicius Partner Giedrius Kolesnikovas and Associate Rokas Jankus supervised the transaction for ILS Holding.